Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: A population-based retrospective cohort study using the PHARMO database

British Journal of Clinical Pharmacology

Volumn 58, Issue 2, 2004, Pages 184-189

  Goettsch, Wim G ^a   Janknegt, Rob ^b   Herings, Ron M C ^a,c  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Antibiotic treatment; Nitrofurantoin; Treatment failure; Trimethoprim; Urinary tract infection

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FACTUAL DATABASE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME; TREATMENT FAILURE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS, URINARY; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NITROFURANTOIN; RETROSPECTIVE STUDIES; TREATMENT FAILURE; TRIMETHOPRIM; URINARY TRACT INFECTIONS;

EID: 3843089629     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02106.x     Document Type: Article

References (23)

1. Lipman T, Price D. Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice. Br Med J 2000; 320: 1114-18.
2. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990; 12: 458-67.
3. Wiersma TJ, Timmermans AE. [Summary of the 'Urinary tract infections' guideline (first revision) of the Dutch College of General Practitioners]. Ned Tijdschr Geneeskd 2001; 145: 735-9.
4. Boel CHE, van de Ven MJGT. Sensitivity of uropathogens in the general population of the Netherlands. Int J Antimicrob Agents 2001; 17 (Suppl. 1): S94.
5. Overbeek BP, Overdijk CJ, Dikhoff JH, Goettsch WC. [High sensitivity of Escherichia coli to antimicrobial agents used for first-line treatment of urinary tract infections; results of an examination of feces of healthy subjects in Friesland]. Ned Tijdschr Geneeskd 2001; 145: 688-91.
6. Ferry S, Burman LG, Holm SE. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis 1988; 20: 535-44.
7. Herings RM. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in The Netherlands, Dissertation. Utrecht: Utrecht University; 1993.
8. Herings RM, Klungel OH. An epidemiological approach to assess the economic burden of NSAID- induced gastrointestinal events in The Netherlands. Pharmacoeconomics 2001; 19: 655-65.
9. Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius AJ, de Boer A. Time trends in lipid lowering drug use in the Netherlands. Has the backlog of candidates for treatment been eliminated? Br J Clin Pharmacol 2002; 53: 379-85.
10. van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol 2002; 54: 168-70.
11. Lawrenson RA, Logie JW. Antibiotic failure in the treatment of urinary tract infections in young women. J Antimicrob Chemother 2001; 48: 895-901.
12. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001; 47: 781-7.
13. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Factors associated with trimethoprim-resistant bacteria isolated from urine samples. J Antimicrob Chemother 1999; 43: 841-3.
14. Arstila T, Huovinen S, Lager K, Lehtonen A, Huovinen P. Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli. J Infect 1994; 29: 9-16.
15. Goettsch W, van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-8.
16. Van der Velden J, De Bakker DH, Claessens AAMC, Schellevis FG. Een nationale studie naar ziekten en verrichtingen in de huisartspraktijk. Basisrapport: morbiditeit in de huisartspraktijk. Utrecht: NIVEL, 1991.
17. Van de Lisdonk AH, Van den Bosch WJHM, Huygen FJA, Lagro-Janssen ALM. Ziekten in de huisartspraktijk. Utrecht: Wetenschappelijke Uitgeverij Bunge, 1994.
18. Janknegt R, Oude Lashof A, Gould IM, van der Meer JW. Antibiotic use in Dutch hospitals 1991-1996. J Antimicrob Chemother 2000; 45: 251-6.
19. MacDonald TM. The economic evaluation of antibiotic therapy: relevance to urinary tract infection. J Antimicrob Chemother 1994; 33 (Suppl. A): 137-45.
20. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. Br Med J 1993; 307: 846-8.
21. Greenberg RN, Reilly PM, Luppen KL, Weinandt WJ, Ellington LL, Bollinger MR. Randomized study of single-dose, three-day, and seven-day treatment of cystitis in women. J Infect Dis 1986; 153: 277-82.
22. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995; 273: 41-5.
23. Sclar DA, Tartaglione TA, Fine MJ. Overview of issues related to medical compliance with implications for the outpatient management of infectious diseases. Infect Agents Dis 1994; 3: 266-73.